These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 201940)

  • 61. Effects of a dopamine beta-hydroxylase inhibitor on amphetamine-induced hyperactivity in rats.
    Khalsa JH; Davis WM
    J Pharm Pharmacol; 1975 Aug; 27(8):620-2. PubMed ID: 239183
    [No Abstract]   [Full Text] [Related]  

  • 62. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
    Rastogi RB; Singhal RL
    J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z; Levitan DE; Lindros KO
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Catecholamine synthesis inhibitors acutely modulate [3H]estradiol binding by specific brain areas and pituitary in ovariectomized rats.
    Thompson MA; Woolley DE; Gietzen DW; Conway S
    Endocrinology; 1983 Sep; 113(3):855-65. PubMed ID: 6135604
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influence of the dopamine-beta-hydroxylase inhibitor FLA 63 on the disposition of barbitone in the mouse.
    Sharkawi M
    J Pharm Pharmacol; 1979 May; 31(5):340-1. PubMed ID: 37309
    [No Abstract]   [Full Text] [Related]  

  • 67. Pharmacological and metabolic interactions between ethanol and the dopamine-beta-hydroxylase inhibitor FLA 63 in mice.
    Sharkawi M
    Neuropharmacology; 1980 Mar; 19(3):277-80. PubMed ID: 6999373
    [No Abstract]   [Full Text] [Related]  

  • 68. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls.
    Cross AJ; Crow TJ; Killpack WS; Longden A; Owen F; Riley GJ
    Psychopharmacology (Berl); 1978 Oct; 59(2):117-21. PubMed ID: 103111
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

  • 71. Regulation and inheritance of dopamine-beta-hydroxylase.
    Stolk JM; Hurst JH; Nisula BC
    Behav Genet; 1982 Feb; 12(1):37-52. PubMed ID: 7092762
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dependence of tyrosine and dopamine-beta-hydroxylases activities on disulfiram and diethyldithiocarbamate level in guinea pig brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):161-8. PubMed ID: 239396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis and characterization of immobilized dopamine beta-hydroxylase in membrane-bound and solubilized formats.
    Markoglou N; Wainer IW
    J Biochem Biophys Methods; 2001 Mar; 48(1):61-75. PubMed ID: 11282402
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in Noradrenergic Synthesis and Dopamine Beta-Hydroxylase Activity in Response to Oxidative Stress after Iron-induced Brain Injury.
    Verduzco-Mendoza A; Mota-Rojas D; Olmos-Hernández A; Avila-Luna A; García-García K; Gálvez-Rosas A; Hidalgo-Bravo A; Ríos C; Parra-Cid C; Montes S; García-López J; Ramos-Languren LE; Pérez-Severiano F; González-Piña R; Bueno-Nava A
    Neurochem Res; 2024 Nov; 49(11):3043-3059. PubMed ID: 39105899
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of diethyldithiocarbamate (DDC), fusaric acid, catecholaminergic and serotonergic receptor blockers on the ascending pathway from the ventrolateral part of the medulla oblongata.
    Kawakami M; Ohno S
    Endocrinol Jpn; 1982 Apr; 29(2):265-70. PubMed ID: 6290207
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evidence for a peripheral effect of fusaric acid, a dopamine beta-hydroxylase inhibitor, on serotonin metabolism.
    Bonnay MM; Guerinot F; Bohuon CJ
    Biochem Pharmacol; 1974 Oct; 23(19):2770-3. PubMed ID: 4419680
    [No Abstract]   [Full Text] [Related]  

  • 77. The anticonvulsant action of methazolamide in mice: antagonism by various inhibitors of dopamine beta-hydroxylase.
    Lotti VJ; Torchiana ML; Stone CA
    Eur J Pharmacol; 1977 Aug; 44(4):387-90. PubMed ID: 19268
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of the central adrenergic system in the regulation of prostaglandin biosynthesis in rat brain.
    Weidenfeld J; Kahbha K; Reches A; Shohami E
    J Neurochem; 1992 Feb; 58(2):694-9. PubMed ID: 1345941
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The antifertility and antiadrenergic actions of thiocarbamate fungicides in laying hens.
    Serio R; Long RA; Taylor JE; Tolman RL; Weppelman RM; Olson G
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):333-42. PubMed ID: 6420938
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The influence of dopamine-beta-hydroxylase inhibitors on avoidance reaction in rat.
    Mogilnicka E; Przewlocka B
    Pol J Pharmacol Pharm; 1975; 27(5):513-9. PubMed ID: 241979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.